Ordinary Rebalance | Solactive Global Healthcare Leaders Index | Effective Date 2nd February 2023
In the ordinary rebalance, the following index composition will be implemented effective open 02.02.2023:
ABBOTT LABORATORIES |
ABBVIE INC |
AGILENT TECHNOLOGIES INC |
ALCON INC |
ALFRESA HOLDINGS CORP ORD |
ALIGN TECHNOLOGY INC |
ALNYLAM PHARMACEUTICALS INC |
AMERISOURCEBERGEN CORP |
AMGEN INC |
AMPLIFON SPA |
ARGENX SE – ADR |
ASAHI INTECC CO LTD |
ASTELLAS PHARMA INC |
ASTRAZENECA PLC |
AVANTOR INC |
BAXTER INTL. |
BAYER AG |
BECTON DICKINSON AND CO |
BIOGEN INC |
BIOMARIN PHARMACEUTICAL INC |
BIOMERIEUX |
BIONTECH SE |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CARDINAL HEALTH INC |
CARL ZEISS MEDITEC AG |
CATALENT INC |
CENTENE |
CHUGAI PHARMACEUTICAL CO LTD ORD |
CIGNA CORP |
COCHLEAR LTD |
COLOPLAST AS CLASS B |
CONVATEC GROUP PLC |
COOPER COMPANIES INC |
CSL LTD ORD |
CSPC PHARMACEUTICAL GROUP LTD |
DAIICHI SANKYO CO LTD ORD |
DANAHER CORP |
DAVITA INC |
DEMANT A/S |
DEXCOM INC |
DIASORIN SPA |
EBOS GROUP LTD |
EDWARDS LIFESCIENCES CORP |
EISAI |
ELEKTA AB |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
EUROFINS SCIENTIFIC SE |
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED |
FRESENIUS MEDICAL CARE AG & CO KGAA |
FRESENIUS SE & CO KGAA |
GENMAB A/S |
GETINGE AB CLASS B |
GILEAD SCIENCES INC |
GRIFOLS SA CLASS A |
GSK PLC |
HALEON PLC |
HCA HEALTHCARE INC |
HENRY SCHEIN INC |
HIKMA PHARMACEUTICALS PLC |
HISAMITSU PHARMACEUTICAL CO INC ORD |
HOLOGIC INC |
HORIZON THERAPEUTICS PLC |
HOYA CORP ORD |
HUMANA INC |
ICON PLC |
IDEXX LABORATORIES INC |
ILLUMINA INC |
INCYTE CORP |
INTUITIVE SURGICAL INC |
IQVIA HOLDINGS INC |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
KONINKLIJKE PHILIPS NV |
KYOWA KIRIN CO LTD |
LABORATORY CRP OF AMER HLDGS |
LONZA GROUP AG |
MCKESSON CORP |
MEDIPAL HLDGS (MEDICEO PALTAC) ORD |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
METTLER-TOLEDO INTL |
MODERNA INC |
NIPPON SHINYAKU CO LTD |
NOVARTIS AG |
NOVO NORDISK A/S |
OLYMPUS |
ONO PHARMACEUTICAL CO LTD ORD |
ORION OYJ CLASS B |
OTSUKA HOLDINGS CO LTD ORD |
PFIZER INC |
QUEST DIAGNOSTICS INC |
RAMSAY HEALTH CARE LTD ORD |
RECORDATI SPA |
REGENERON PHARMACEUTICALS |
RESMED INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
RYMAN HEALTHCARE GROUP LTD ORD |
SANOFI SA |
SANTEN PHARMACEUTICAL CO LTD ORD |
SARTORIUS AG PREF |
SARTORIUS STEDIM BIOTECH SA |
SEAGEN INC |
SHIMADZU CORP ORD |
SHIONOGI & CO LTD ORD |
SIEMENS HEALTHINEERS AG |
SINO BIOPHARMACEUTICAL LTD ORD |
SMITH & NEPHEW PLC |
SONIC HEALTHCARE (TECH AUST) ORD |
STERIS PLC |
STRAUMANN HOLDING AG |
STRYKER CORP |
SUMITOMO PHARMA CO LTD |
SUZUKEN CO LTD ORD |
SWEDISH ORPHAN BIOVITRUM AB |
SYSMEX CORP ORD |
TAISHO PHARMACEUTICAL HOLDINGS CO LTD |
TAKEDA PHARMACEUTICAL |
TELEFLEX INC |
TERUMO CORP |
TEVA PHARMACEUTICAL IND LTD |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
UNITEDHEALTH GROUP INC |
VEEVA SYSTEMS INC |
VERTEX PHARMACEUTICALS INC |
VIATRIS INC |
VITROLIFE AB |
WATERS CORP |
WEST PHARMACEUTICAL SERVICES INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |